2m 2m 2m 2m 2m 2m 2m
Regeneron Pharma (REGN)
NASDAQ
$801.76-$3.26 (-0.40%)
Price as of Oct 26, 2026 3:27 PM EDT- $81.4BMarket Cap
- 40.00%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$801.76-$3.26 (-0.40%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $805.02 | ||
Change | -$14.07 (-1.72%) | ||
Open | $819.09 | ||
High | $819.09 | ||
Low | $801.22 | ||
Previous Close | $819.09 | ||
Volume | 527,740 | ||
30-Day Average Volume | 693,691 | ||
1-Week Change | 1.81% | ||
1-Month Change | 0.40% | ||
1-Year Change | 40.00% | ||
3-Year Change | 2.15% | ||
5-Year Change | 41.98% | ||
Fundamentals | |||
Shares Outstanding | 101.1M | ||
Total Assets | $41.7B | ||
Market Cap | $81.4B | ||
Enterprise Value | $80.9B | ||
Period: QTR TTM FY | |||
Revenue | $1.6B | ||
Net Income | $1.3B | ||
Free Cash Flow | $572.8M | ||
EBIT | $1.5B | ||
EBITDA | $1.7B | ||
Net Working Capital | $12.9B | ||
EPS | $12.23 | ||
Enterprise Value/EBITDA | 49 | ||
Enterprise Value/Revenue | 49 | ||
P/B | 3 | ||
P/E | 66 | ||
PEG | 1 | ||
Price/Free Cash Flow | 142 | ||
Price/Operating Cash Flow | 100 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.47% | ||
Trailing Annual Dividend Yield | 0.46% | ||
Ex-Dividend Date | 08/18/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield